CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $686,234 | -48.6% | 364,920 | -1.8% | 0.00% | – |
| Q2 2023 | $1,334,431 | +6.5% | 371,708 | 0.0% | 0.00% | – |
| Q1 2023 | $1,252,655 | +217374.8% | 371,708 | 0.0% | 0.00% | – |
| Q4 2022 | $576 | -99.9% | 371,708 | +0.9% | 0.00% | – |
| Q3 2022 | $501,000 | -37.8% | 368,519 | +0.2% | 0.00% | – |
| Q2 2022 | $805,000 | -64.1% | 367,610 | -47.7% | 0.00% | – |
| Q1 2022 | $2,241,000 | -22.9% | 702,715 | +1.3% | 0.00% | – |
| Q4 2021 | $2,907,000 | -48.6% | 693,915 | -0.5% | 0.00% | -100.0% |
| Q3 2021 | $5,660,000 | +8.1% | 697,165 | +0.5% | 0.00% | 0.0% |
| Q2 2021 | $5,238,000 | -8.2% | 693,833 | +5.5% | 0.00% | 0.0% |
| Q1 2021 | $5,706,000 | +26.0% | 657,459 | +15.7% | 0.00% | 0.0% |
| Q4 2020 | $4,530,000 | +7.8% | 568,407 | +7.9% | 0.00% | 0.0% |
| Q3 2020 | $4,201,000 | -7.3% | 526,855 | +15.1% | 0.00% | 0.0% |
| Q2 2020 | $4,531,000 | +38.9% | 457,757 | +8.4% | 0.00% | 0.0% |
| Q1 2020 | $3,263,000 | +17.9% | 422,172 | -41.3% | 0.00% | – |
| Q4 2019 | $2,768,000 | +56.0% | 719,304 | +103.9% | 0.00% | – |
| Q3 2019 | $1,774,000 | -22.6% | 352,761 | +1.7% | 0.00% | -100.0% |
| Q2 2019 | $2,292,000 | -6.1% | 346,839 | +7.6% | 0.00% | 0.0% |
| Q1 2019 | $2,440,000 | -49.9% | 322,385 | -46.5% | 0.00% | 0.0% |
| Q4 2018 | $4,872,000 | +32.6% | 602,996 | +111.7% | 0.00% | 0.0% |
| Q3 2018 | $3,674,000 | +34.8% | 284,819 | +19.1% | 0.00% | 0.0% |
| Q2 2018 | $2,726,000 | +167.0% | 239,199 | +65.1% | 0.00% | – |
| Q1 2018 | $1,021,000 | +17.6% | 144,882 | +8.5% | 0.00% | – |
| Q4 2017 | $868,000 | +10.2% | 133,562 | +5.1% | 0.00% | – |
| Q3 2017 | $788,000 | +44.3% | 127,125 | 0.0% | 0.00% | – |
| Q2 2017 | $546,000 | -4.2% | 127,125 | +0.2% | 0.00% | – |
| Q1 2017 | $570,000 | -17.2% | 126,883 | +0.5% | 0.00% | – |
| Q4 2016 | $688,000 | -14.5% | 126,277 | +0.3% | 0.00% | – |
| Q3 2016 | $805,000 | +40.7% | 125,873 | +0.1% | 0.00% | – |
| Q2 2016 | $572,000 | +16.0% | 125,772 | 0.0% | 0.00% | – |
| Q1 2016 | $493,000 | -29.7% | 125,772 | -0.1% | 0.00% | – |
| Q4 2015 | $701,000 | -12.8% | 125,873 | -1.3% | 0.00% | – |
| Q3 2015 | $804,000 | +2.9% | 127,546 | +0.2% | 0.00% | – |
| Q2 2015 | $781,000 | -53.5% | 127,344 | +0.1% | 0.00% | -100.0% |
| Q1 2015 | $1,678,000 | – | 127,243 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |